Immuneering Corp (IMRX)
2.19
-0.06
(-2.67%)
USD |
NASDAQ |
Dec 26, 09:52
Immuneering Cash from Investing (Quarterly): -5.415M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 34.27M |
| PTC Therapeutics Inc | -42.68M |
| AN2 Therapeutics Inc | 18.72M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.47M |
| Cash from Financing (Quarterly) | 4.365M |
| Free Cash Flow | -52.51M |
| Free Cash Flow Per Share (Quarterly) | -0.4516 |
| Free Cash Flow Yield | -81.18% |